Caricamento...
Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
INTRODUCTION: Clinical trials in Alzheimer's disease are aimed at early stages of disease, including preclinical Alzheimer's disease. The high cost and time required to screen large numbers of participants for Aβ pathology impede the development of novel drugs. This study's objective...
Salvato in:
| Pubblicato in: | Alzheimers Dement (Amst) |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045949/ https://ncbi.nlm.nih.gov/pubmed/27722193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.07.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|